Senators call for greater data transparency

The recent release of federal data doesn't go far enough, according to Senators Chuck Grassley (R-Iowa), and Ron Wyden (D-Ore.). They are calling for more action to make Medicare claims data fully transparent.

“Medicare is a $500 billion program with billions of dollars going out in error each year,” Grassley said in a release. “The bad actors get bigger and bolder all the time. They stay out of law enforcement’s reach all too often. It’s time to try new things.

“More transparency about billing and payments increases public understanding of where tax dollars go and foster accountability. The bad actors might be dissuaded if they knew their actions were subject to the light of day,” he said.

“Medicare claims data transparency seems to be moving in the right direction, but we’re just not there yet,” Wyden said. “Aggregated data and statistical averages can hide differences between providers and settings, and don’t allow Americans to truly compare their healthcare choices. In order to enjoy the benefits of full transparency, Medicare claims data should be readily available to the public.”

Grassley and Wyden plan to reintroduce the Medicare Data Access for Transparency and Accountability Act (Medicare DATA Act), which would require the Secretary of Health and Human Services to issue regulations to make available a searchable Medicare payment database that the public can access at no cost. The bill also clarifies that data on Medicare payments to physicians and suppliers do not fall under a Freedom of Information Act exemption.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.